Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07425015 · ClinicalTrials.gov registry record · NA
Ambulatory Long Length URodynamics Evaluation
A NA study of Benign Prostatic Hyperplasia and Urinary Bladder, Overactive, sponsored by Bright Uro.
- Recruiting
- Registry status
- NA
- Development phase
- 101
- Enrollment target
- 7
- Study locations
NCT07425015 is a NA study of Benign Prostatic Hyperplasia and Urinary Bladder, Overactive that is actively recruiting participants, run by Bright Uro. The registered enrollment target is 101 participants, below the 549-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (82% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT07425015, a NA study of Benign Prostatic Hyperplasia and Urinary Bladder, Overactive, is actively recruiting participants, sponsored by Bright Uro.
- RECRUITING
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
- 7
- Study locations
Study Summary
A prospective, open-label, single arm interventional trial evaluating the safety and performance of the in-clinic and extended monitoring of the lower urinary tract using the Glean Urodynamics System.
Conditions Studied
Interventions
- DEVICE Glean Urodynamics System
Study Locations (7)
Maryland
- Chesapeake Urology Associates - Hanover
- Chesapeake Urology Associates - Owings Mills
Missouri
- Urology of St. Louis - St Louis
Ohio
- MetroHealth - Cleveland
South Carolina
- Southern Urogynecology Wellness & Aesthetics - West Columbia
South Dakota
- Sanford Health - Sioux Falls
Texas
- Urology Partner of North Texas - Arlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2026-02 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07425015
The ClinicalTrials.gov registry entry for NCT07425015 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 549-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (82% lower). The listed sponsor is Bright Uro, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 1 intervention - of which Glean Urodynamics System is the first listed.
NCT07425015 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Maryland, Missouri, Ohio.
Frequently Asked Questions
What is clinical trial NCT07425015 about?
NCT07425015 is a clinical study titled "Ambulatory Long Length URodynamics Evaluation". A prospective, open-label, single arm interventional trial evaluating the safety and performance of the in-clinic and extended monitoring of the lower urinary tract using the Glean Urodynamics System.
What is the current status of trial NCT07425015?
This trial is currently recruiting. It is a NA study. The enrollment target is 101 participants. The study started on 2026-02. Estimated completion is 2027-06.
What conditions does trial NCT07425015 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia, Urinary Bladder, Overactive, Urology, Urodynamics, Urinary Incontinence (UI).
What interventions are being tested in trial NCT07425015?
The interventions under investigation include: Glean Urodynamics System (DEVICE).
Who is sponsoring clinical trial NCT07425015?
This trial is sponsored by Bright Uro, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07425015 being conducted?
This trial has 7 study locations across Maryland, Missouri, Ohio, South Carolina, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Benign Prostatic Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
RECRUITING · NA
-
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
RECRUITING · NA
-
PRescription Exercise for Older Men With Urinary Disease
RECRUITING · NA
-
Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.